The underlying mechanism and therapeutic potential of IFNs in viral-associated cancers

Life Sci. 2025 Jan 15:361:123301. doi: 10.1016/j.lfs.2024.123301. Epub 2024 Dec 13.

Abstract

Interferons (IFNs) are a diverse family of cytokines secreted by various cells, including immune cells, fibroblasts, and certain viral-parasitic cells. They are classified into three types and encompass 21 subtypes based on their sources and properties. The regulatory functions of IFNs closely involve cell surface receptors and several signal transduction pathways. Initially investigated for their antiviral properties, IFNs have shown promise in combating cancer-associated viruses, making them a potent therapeutic approach. Most IFNs have been identified for their role in inhibiting cancer; however, they have also demonstrated cancer-promoting effects under specific conditions. These mechanisms primarily rely on immune regulation and cytotoxic effects, significantly impacting cancer progression. Despite widespread use of IFN-based therapies in viral-related cancers, ongoing research aims to develop more effective treatments. This review synthesizes the signal transduction pathways and regulatory capabilities of IFNs, highlighting their connections with viruses, cancers, and emerging clinical treatments.

Keywords: Cancer regulation; Cancer treatment; Interferons.

Publication types

  • Review

MeSH terms

  • Animals
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Humans
  • Interferons* / metabolism
  • Interferons* / therapeutic use
  • Neoplasms* / drug therapy
  • Neoplasms* / immunology
  • Neoplasms* / virology
  • Signal Transduction* / drug effects
  • Virus Diseases / drug therapy
  • Virus Diseases / immunology

Substances

  • Interferons
  • Antiviral Agents